{
  "id": "dka_mpm_score",
  "title": "Diabetic Ketoacidosis Mortality Prediction Model (DKA MPM) Score",
  "description": "Predicts in-hospital mortality in patients with diabetic ketoacidosis using clinical and laboratory parameters at presentation, 12 hours, and 24 hours",
  "category": "endocrinology",
  "version": "2002",
  "parameters": [
    {
      "name": "severe_comorbidities",
      "type": "string",
      "required": true,
      "description": "Presence of severe comorbidities (immunosuppression, previous MI, COPD, cirrhosis, CHF, and/or previous stroke)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 6,
        "no": 0
      }
    },
    {
      "name": "ph_less_than_7",
      "type": "string",
      "required": true,
      "description": "pH < 7.0 at presentation",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 4,
        "no": 0
      }
    },
    {
      "name": "insulin_over_50_units",
      "type": "string",
      "required": true,
      "description": "More than 50 units of regular insulin required over first 12 hours",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 4,
        "no": 0
      }
    },
    {
      "name": "glucose_over_300_at_12h",
      "type": "string",
      "required": true,
      "description": "Serum glucose > 300 mg/dL (16.7 mmol/L) after 12 hours",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 4,
        "no": 0
      }
    },
    {
      "name": "depressed_mental_state_24h",
      "type": "string",
      "required": true,
      "description": "Depressed mental state at 24 hours after presentation (as determined by examiner)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 4,
        "no": 0
      }
    },
    {
      "name": "fever_24h",
      "type": "string",
      "required": true,
      "description": "Fever at 24 hours after presentation (axillary temperature ≥38°C / 100.4°F)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": ["yes", "no"],
      "points": {
        "yes": 3,
        "no": 0
      }
    }
  ],
  "result": {
    "name": "dka_mpm_score_result",
    "type": "integer",
    "unit": "points",
    "description": "DKA MPM Score for mortality prediction (0-25 points)"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 14,
        "stage": "Low Risk",
        "description": "Low risk of in-hospital mortality",
        "interpretation": "Patients with DKA MPM Score 0-14 points have low risk of in-hospital mortality (0.86%). Standard DKA management and monitoring protocols are appropriate. These patients typically have good prognosis with appropriate treatment."
      },
      {
        "min": 15,
        "max": 18,
        "stage": "High Risk",
        "description": "High risk of in-hospital mortality",
        "interpretation": "Patients with DKA MPM Score 15-18 points have high risk of in-hospital mortality (20.8%). Enhanced monitoring, aggressive management, and consideration for intensive care unit admission is recommended. Close monitoring of fluid balance, electrolytes, and mental status is crucial."
      },
      {
        "min": 19,
        "max": 25,
        "stage": "Very High Risk",
        "description": "Very high risk of in-hospital mortality",
        "interpretation": "Patients with DKA MPM Score 19-25 points have very high risk of in-hospital mortality (93.3%). Immediate intensive care unit admission, aggressive resuscitation, and specialized multidisciplinary management are indicated. Consider early family discussions regarding prognosis and goals of care."
      }
    ]
  },
  "clinical_applications": [
    "Risk stratification of patients with diabetic ketoacidosis",
    "Guiding intensity of monitoring and care in DKA patients",
    "Assisting in ICU admission decisions for DKA patients",
    "Prognostic counseling for patients and families",
    "Quality improvement initiatives in DKA management",
    "Research stratification in DKA studies",
    "Healthcare resource allocation planning"
  ],
  "scoring_methodology": {
    "calculation": "Sum of all parameter points based on presence/absence of risk factors",
    "timing": "Assessment at presentation (0h), 12 hours, and 24 hours after presentation",
    "total_score_range": "0-25 points",
    "risk_categories": "Low risk (0-14), High risk (15-18), Very high risk (19-25)"
  },
  "limitations": [
    "Not externally validated - use with caution",
    "Not intended for routine patient disposition decisions",
    "APACHE II Score may be a better mortality predictor",
    "Limited to adult patients with confirmed DKA diagnosis",
    "Not validated in pediatric populations",
    "Requires assessment at multiple time points (0h, 12h, 24h)",
    "Inter-observer variability in assessment of mental state"
  ],
  "contraindications": [
    "Pediatric patients (< 18 years old)",
    "Patients without confirmed DKA diagnosis",
    "Use as sole basis for clinical decision-making"
  ],
  "validation": {
    "population": "Adult patients with diabetic ketoacidosis",
    "study_size": "154 patients (52 males, mean age 58 ± 12 years)",
    "mortality_rate": "13% in-hospital mortality (20/154 patients)",
    "settings": ["Emergency departments", "Intensive care units", "Internal medicine wards"],
    "evidence_basis": "Single-center retrospective study - not externally validated"
  },
  "references": [
    "Efstathiou SP, Tsiakou AG, Tsioulos DI, et al. A mortality prediction model in diabetic ketoacidosis. Clin Endocrinol (Oxf). 2002;57(5):595-601. doi: 10.1046/j.1365-2265.2002.01636.x.",
    "Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. doi: 10.2337/dc09-9032.",
    "Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40. doi: 10.1038/s41572-020-0165-1."
  ],
  "formula": "DKA MPM Score = (Severe comorbidities × 6) + (pH < 7.0 × 4) + (>50 units insulin in 12h × 4) + (Glucose >300 mg/dL at 12h × 4) + (Depressed mental state at 24h × 4) + (Fever at 24h × 3)",
  "notes": [
    "Score requires assessment at three time points: presentation, 12 hours, and 24 hours",
    "Severe comorbidities include immunosuppression, previous MI, COPD, cirrhosis, CHF, and/or previous stroke",
    "pH measurement should be arterial blood gas",
    "Regular insulin requirement includes only regular insulin, not long-acting forms",
    "Glucose measurement at 12 hours should be serum glucose",
    "Mental state assessment is subjective and requires clinical judgment",
    "Fever is defined as axillary temperature ≥38°C (100.4°F)",
    "Not externally validated - use clinical judgment in conjunction with score",
    "Consider APACHE II score as alternative mortality predictor",
    "Not intended as sole basis for clinical decision-making"
  ]
}